STAPHYLOCIDE:
Delivering Antibiotic Resistance Gene Silencing Mechanisms to a MRSA Population using Bacterial Conjugation
STAPHYLOCIDE : Delivering Antibiotic Resistance Gene Silencing - - PowerPoint PPT Presentation
STAPHYLOCIDE : Delivering Antibiotic Resistance Gene Silencing Mechanisms to a MRSA Population using Bacterial Conjugation "The problem is so serious that it threatens the achievements of modern medicine. - World Health Organization,
STAPHYLOCIDE:
Delivering Antibiotic Resistance Gene Silencing Mechanisms to a MRSA Population using Bacterial Conjugation
"The problem is so serious that it threatens the achievements of modern medicine. ”
Global Report on Surveillance 2014
MRSA Cases by Year
16 14 12 7 4 2
2 4 6 8 10 12 14 16 18Number of new antimicrobial agents approved by the FDA for humans Cases in Thousands
MRSA resistance in a nutshell
Penicillin PBP Chromosome Cell Wall
Staphylococcus aureus
MRSA resistance in a nutshell
Methicillin Resistant Staphylococcus aureus
mecA gene Penicillin PBP2A Chromosome Cell Wall
MRSA STAPHYLOCIDE
IMPROVING THE REGISTRY
9
Promoters
Ribosome Binding Sites
Terminators
Staphylococcal Parts
Selection Markers
Origin of Replication
Reporters
10
Staphylococcal Strain
11
Reporter Gene: DsRed
12
BBa_K1323017
ErmR
CmR
P S RFP Expression Cassette (BBa_J04450) VF2 VR
Improved pSB1C3 by making it more versatile:
pSB1C3 parts Parts we introduced
13
Shuttle Vector: Antibiotic Resistance
resistance
DELIVER SILENCE TRANSLATE
SILENCE
Design Translation Transcription
16
Silence
YFP mRNA Transcription Translation YFP
17
Silence: CRISPRi
dCas9-sgRNA complex blocks RNA polymerase
18
Silence: CRISPRi Network
19
Silence: CRISPRi Results
20
Silence: CRISPRi Sensitivity
degradation rate Therefore…
translation will improve silencing!
21
Silence: RNAi
sRNA-Hfq complex blocks ribosome
22
Silence: RNAi Network
23
Silence: RNAi Results
24
Silence: Design
YFP mRNA Transcription Translation YFP
CRISPRi
dCas9-sgRNA Complex
25
pSB1A3
AmpR
ErmR
sgRNA
Pconst
Silence: CRISPRi
dCas9 xylose XylR
TT26
Silence: Design
YFP mRNA Transcription Translation YFP
RNAi CRISPRi
dCas9-sgRNA Complex Hfq-sRNA Complex
27
pSB1A3
AmpR
ErmR
sRNA
Pconst
Silence: RNAi
Hfq xylose
TTxylR
28
Silence: RNAi Design
YFP CDS Scar RBS YFP mRNA 5’ 3’ …
sRNA 1 sRNA 2 sRNA 3
29
Co- Transform
Silence: RNAi Preliminary Tests
pSB3K3
Measure fluorescence
pSB1A3
30
Silence: RNAi Preliminary Test
YFP Alone Control sRNA1 sRNA2 sRNA3 RFU/OD600
31
regulation
Silence: Future Directions
DELIVER
Modeling Lab Design
33
Conjugation in Staphylococcus
Solid Surface
Recipient Donor
34
Deliver: Conjugation
Advantages:
to an underdeveloped area of research Disadvantage:
35
Conjugation Parts: pGO1
pGO1: S. aureus conjugational plasmid
2.2 kb
trs Region: Still in progress
trs: 13.5 kb
36
Conjugation Test Construct
pSBS1A3
ErmR
AmpR
P
DsRed TT RBSS Recipients
Donor Transconjugants Filter Mating Assays
37
Deliver: Modeling
Challenge: Modeling conjugation between cells spread across a lab plate or a patient’s skin
38
Deliver: Modeling
Two novel models: Partial Differential Equation (PDE) is deterministic and computationally efficient Agent-Based Approach is stochastic and considers the spatial relationships between individual cells Output: time needed for silencing to spread
39
Deliver: Agent Based Model
Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 0 h t = 0 h
40
Deliver: Agent Based Model
Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 6 h t = 6 h
41
Deliver: Agent Based Model
Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 12 h t = 12 h
42
Deliver: Agent Based Model
Staphylococcus conjugation rate Susceptible Staphylococcus MRSA Sufficient conjugation rate t = 24 h t = 24 h
43
Deliver: Agent Based Results
44
Deliver: PDE Model Results
45
Deliver: Future Uses of Model
Find igem-waterloo on GitHub!
46
PCR mutagenesis and selective mating assays
Deliver: Future Directions
TRANSLATE
Adaptability Safety Market Viability
48
Translate: Commercialization
STAPHYLOCIDE Plasmid
Conjugation Parts
49
Translate: Commercialization
50
Translate: Commercialization
51
Translate: Commercialization
β-Lactam Antibiotic
52
Translate: Commercialization
β-Lactam Antibiotic
53
Translate: Adaptability
DELIVER SILENCE TRANSLATE
55
Submitted 19 BioBricks, 8 characterized
Improved BioBrick backbone to develop shuttle vector
Produced and validated several models of the silencing and delivery systems
Explored scalability of project
Collaborated on uOttawa iGEM & Virginia Tech project and assisted with oGEM
Accomplishments
56
Accomplishments: Outreach
High School Enrichment Program
Science Club
Lab Skills Video Series
Sir John A. Macdonald Secondary School
57
Acknowledgements
Aucoin
Ingalls
Scott
Charles
Moffat
Doxey
Questions?
59
Bayer, M. G., Heinrichs, J. H., & Cheung, A. L. (1996). The molecular architecture of the sar locus in Staphylococcus aureus. Journal of Bacteriology, 178(15): 4563-70 Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. a. (2013). Programmable repression and activation of bacterial gene expression using an engineered CRISPR-CasReferences
60
Malone, C. L., Boles, B. R., Lauderdale, K. J., Thoendel, M., Kavanaugh, J. S., & Horswill, A. R. (2009). Fluorescent Reporters for Staphylococcus aureus. Journal of Microbiological Methods, 77(3): 251-260. Qi, L. S., Larson, M. H., Gilbert, L. a, Doudna, J. a, Weissman, J. S., Arkin, A. P., & Lim, W. a. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of geneReferences